Stay updated on AMG 176 in Relapsed/Refractory Myeloma & Leukemia Clinical Trial

Sign up to get notified when there's something new on the AMG 176 in Relapsed/Refractory Myeloma & Leukemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AMG 176 in Relapsed/Refractory Myeloma & Leukemia Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-11-01T01:40:24.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” across NIH content.
    Difference
    0.4%
    Check dated 2026-10-25T01:48:36.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T01:33:11.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T02:05:49.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The record history now shows a new site revision added (Revision: v3.7.0) replacing the previous Revision: v3.6.6. This reflects a platform version update from 3.6.6 to 3.7.0 rather than changes to trial data.
    Difference
    0.1%
    Check dated 2026-09-20T00:50:53.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The new screenshot reveals an expanded version history with color-coded highlights indicating additions and deletions across various sections, reflecting how the study record has evolved over time.
    Difference
    0.1%
    Check dated 2026-09-05T22:07:52.000Z thumbnail image

Stay in the know with updates to AMG 176 in Relapsed/Refractory Myeloma & Leukemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AMG 176 in Relapsed/Refractory Myeloma & Leukemia Clinical Trial page.